Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Karn Wijarnpreecha
Associate Clinical Professor, Internal Medicine
College of Medicine - Phoenix
Full Page
Overview
Research
More
Publications
(350)
Recent
Metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality among adults in the United States
2024
metabolic dysfunction,
mortality,
united states,
adults
Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study
2024
alcohol intake,
mortality,
prevalence,
longitudinal effects
The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donors
2024
liver transplantation,
meta-analysis,
adverse outcomes,
donor health
Geographical and sociodemographic epidemiology of inflammatory bowel disease in young females from 2010 to 2019
2024
inflammatory bowel disease,
epidemiology,
geographical analysis,
sociodemographic factors
Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study
2024
diabetes,
obesity
Global prevalence, clinical characteristics, surveillance, treatment allocation, and outcomes of alcohol-associated hepatocellular carcinoma
2024
clinical characteristics,
surveillance
Su1528 RISING PREVALENCE AND LONGITUDINAL EFFECTS ON MORTALITY BASED ON SPECTRUM OF ALCOHOL INTAKE IN STEATOTIC LIVER DISEASE MASLD, METALD AND ALD) A US POPULATION STUDY
2024
alcohol intake,
liver disease,
mortality,
longitudinal effects
Su1534 RACIAL DISPARITIES IN PREVALENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
2024
racial disparities,
cirrhosis,
metabolic dysfunction,
extrahepatic manifestations
Estimated pulse wave velocity in metabolic dysfunction‐associated steatotic liver disease and all‐cause/cause‐specific mortality
2024
liver disease,
cardiovascular risk,
metabolic dysfunction,
mortality,
pulse wave velocity
Associations between metabolic hyperferritinaemia, fibrosis‐promoting alleles and clinical outcomes in steatotic liver disease
2024
metabolic,
liver disease,
fibrosis,
genetic,
clinical outcomes
